EUCTR2004-005184-15-GB进行中（未招募）不适用
Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism - CHATS
Christie Hospital NHS Trust0 个研究点目标入组 80 人开始时间: 2005年4月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients aged 20-70 with hypopituitarism and free thyroxine levels within the lower third of the reference range
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •thyrotoxicosis, uncontrolled cardiac arrhythmias or unstable ischaemic heart disease, treatment with amiodarone/lithium within the last 6 months, acromegaly, Cushing's disease
研究者
相似试验
已完成
不适用
CHATS: Central Hypothyroidism And Adjusted Thyroxine Dose Study (Chats): Impact Of Increasing Free Thyroxine Levels In Patients With HypopituitarismHypopituitarismISRCTN69841377Record Provided by the NHSTCT Register - 2006 Update - Department of Health80
已完成
不适用
Congenital central hypothyroidism plusminus ACTH or growth hormone deficiency: etiology and outcomeabsent stimulation of thyroidCongenital hypothyroidism of central origin1001469910021112NL-OMON47244Academisch Medisch Centrum170
招募中
3 期
Evaluation of effect of thyroid hormone therapy on prognosis of patients with traumatic brain injuryDiffuse traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20130310012776N6Vice chancellor of research. Shiraz University of medical sciences266
已完成
不适用
Combined treatment with thyroxine plus triiodothyronine for primary hypothyroidism in humansHypothyroidismISRCTN85948357Hospital Ramón y Cajal, Madrid (Spain)
进行中（未招募）
不适用
Substitutive therapy of hypothyroid patients with L-thyroxine (T4) plus T3 sulfate (T3S). A Phase II, open-label, single centre, parallel group study on therapeutic efficacy and tolerability - NDThyroidectomized patients without endogenous hormonal production (Tg<5) in stable substitutive therapy with T4MedDRA version: 9.1Level: LLTClassification code 10021117EUCTR2010-018663-42-ITBRACCO